Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021 is a research paper published in JAMA (2021). On theSindex it has a DataRank of 0.929. It has been cited 489 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.929
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Intramural CDC HHS
Grant: CC999999
FWCI
54.34
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Evaluation of the safety profile of COVID-19 vaccines: a rapid review
Additional file 1 of Evaluation of the safety profile of COVID-19 vaccines: a rapid review
Additional file 1 of The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa
Additional file 1 of The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa
Additional file 2 of The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa
Additional file 2 of The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa